Publications les plus récentes (2006- )
V. KUBICEK, T. VITHA, J. KOTEK, P. HERMANN, L. VANDER ELST, R.N. MULLER, I. LUKES, J.A. PETERSContrast Med. Mol. Imaging, accepted (2010)
Magnetic iron oxide nanoparticles for biomedical applications S. LAURENT, J.L. BRIDOT, L. VANDER ELST, R. MULLER, Future Medicinal Chemistry, accepted (2010)
Development of magnetic chromatography to sort polydisperse nanoparticles in ferrofluidsD. FORGE, Y. GOSSUIN, A. ROCH, S. LAURENT, L. VANDER ELST, R.N. MULLERContrast Med. Mol. Imaging, accepted (2010)
Iron oxide particles covered with Hexapeptides Targeted to Phosphatidylserine as MR Biomarkers of Tumor Cell Death K.A. RADERMACHER, S. BOUTRY, S. LAURENT, L. VANDER ELST, I. MAHIEU, C. BOUZIN, J. MAGAT, V.GREGOIRE, O. FERON, R.N. MULLER, B.F. JORDAN, B. GALLEZ, Contrast Med. Mol. Imaging, accepted (2010)
High quality and tuneable silica shell–magnetic core nanoparticles,C. Vogt, M. Toprak, M. Muhammed, S. Laurent, J. Bridot, et R. Muller, Journal of Nanoparticle Research. (Online first)
Reduced blood brain barrier breakdown in P-selectin deficient mice following transient ischemic stroke: a future therapeutic target for treatment of stroke, A.Y. Jin, U.I. Tuor, D. Rushforth, J. Kaur, R.N. Muller, J.L. Petterson, S. Boutry, et P.A. Barber,BMC Neuroscience, vol. 11, 2010, p. 12.
Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate: synthesis and characterization, Rerat V, Laurent S, Burtea C, Driesschaert B, Pourcelle V, Vander Elst L, Muller RN, Marchand-Brynaert J, Bioorg Med Chem Lett, 20(6), (2010), 1861-1865
Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry and electrospray mass spectrometry.C. Henoumont, L. Vander Elst, S. Laurent, R.N. Muller,J. Phys.Chem.B (2010) 114, 3689-3697
H-1 NMR relaxivity of aqueous suspensions of titanium dioxide nanoparticles coated with a gadolinium(III) chelate of a DOTA-monoamide with a phenylphosphonate pendant arm.REHOR I, KUBICEK V, KOTEK J., HERMANN P., LUKES I., SZAKOVA J., VANDER ELST L., MULLER R.N., PETERS J.A.J. Mater. Chem 19, (2009) 1494-1500
How to perform accurate and reliable measurements of longitudinal and transverse relaxation times of MRI contrast media in aqueous solutions.C. Henoumont, S. Laurent, L. Vander Elst, Contrast Media Mol. Imaging, 4(6) (2009) 312-321
Lanthanide Complexes for Magnetic Resonance and Optical Molecular ImagingS. LAURENT, L. VANDER ELST, R.N. MULLER, Q. J. Nucl. Med. Mol Imaging, 53 (2009), 586-603
L’imagerie moléculaire, un nouvel outil multidisciplinaire de la recherche biomédicale, Laurent S, Burtea C, Boutry S, Elément, 3, 2009, 20-23..
Molecular MRI of VCAM-1 expression in inflammatory lesions using a peptide-vectorized paramagnetic imaging probe.Burtea C, Laurent S, Port M, Lancelot E, Ballet S, Rousseaux O, Toubeau G, Vander Elst L, Corot C, Muller RN, J Med Chem, 52(15), (2009), 4725-4742.
Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaquesBurtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN, Mol Pharm, (2009), 6(6):1903-19.
How to quantify iron in an aqueous or biological matrix: a technical note.Boutry S, Forge D, Burtea C, Mahieu I, Murariu O, Laurent S, Vander Elst L, Muller RN, Contrast Media Mol Imaging, 4(6) (2009),299-304.
R&D of novel medicinal materials for curing cancer: sugar modified Gd-DTPA MRI contrast agents and phospha sugar anti-cancer agents J. YAMASHITA, M. YAMASHITA, M. FUJIE, K. ASAI T. SUYAMA, S. ITO, V.K. REDDY, M. YAMADA, K. OGAWA, N. OZAKI, S. NAKAMURA, T. AOKI, G. YU, K. AOSHIMA, T. KATO, N. KAMIKAGE, K. KIYOFUJI, Y. TAKEHARA, H. SAKAHARA, H. TAKAYANAGI, T. OSHIKAWA, S. LAURENT, C. BURTEA, L. VANDER ELST, R.N. MULLER, Journal of Automation, Mobile Robotics & Intelligent Systems (JAMRIS), 3(4), (2009) 80-83
Gd(III) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(III) complexes for imaging and radiotherapy of calcified tissues.,VITHA T, KUBÍCEK V, KOTEK J, HERMANN P, VANDER ELST L, MULLER RN, LUKES I, PETERS JA.Dalton Trans. 7(17), 3204-3214. (2009)
Produits de contraste en IRMS. LAURENT, L. VANDER ELST, R.N.MULLER, EMC (Elsevier Masson SAS, Paris), Radiologie et imagerie médicale –principes et technique –radioprotection, 35-236-A-10 (2009)
Iron oxide based MR contrast agents: from chemistry to cell labeling, S. Laurent, S. Boutry, I. Mahieu, L. Vander Elst, et R.N. Muller, Current Medicinal Chemistry, vol. 16, 2009, p. 4712-4727.
In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy, K.A. Radermacher, N. Beghein, S. Boutry, S. Laurent, L. Vander Elst, R.N. Muller, B.F. Jordan, et B. Gallez, Investigative Radiology, vol. 44 No. 7, Jul. 2009, p. 398-404.
Etude quantitative des interactions non covalentes entre l’albumine sérique humaine et les petites molécules. Apport de la spectrométrie de masse à l’imagerie moléculaire S. LAURENT, V. HENROTTE, L. VANDER ELST, R.N. MULLER, Chimie Nouvelle, vol 27, n°101, 15-23 (2009)
Relaxometric, Thermodynamic and Kinetic Studies of Lanthanide(III) Complexes of DO3A-based PropylphosphonateI. MAMEDOV, P. TABORSKY, P. LUBAL, S. LAURENT, L. VANDER ELST, H. MAYER, N.K. LOGOTHETIS, G. ANGELOWSKI,Eur. J. Inorg. Chem., 22, 3298 – 3306 (2009)
Lanthanide complexes on Ag nanoparticles: Designing contrast agents for Magnetic Resonance ImagingT.S. SIDDIQUI, A. JANI, F. WILLIAMS, F. YAO, Y. ZAIM WADGHIRI, R.N. MULLER, L. VANDER ELST, S. LAURENT, J. Coll. Interface Sci., 337(1), 88-96 (2009)
Contrast Agents for MRI: Recent Advances”S. LAURENT, L.VANDER ELST, R.N. MULLER dans “Encyclopedia of Magnetic Resonance”, eds R. K. Harris and R. Wasylishen, John Wiley: Chichester. DOI: 10.1002/9780470034590.emrstm1049. Publié le 15 Mars 2009.
Identification of Peptide Ligands that Target Apoptotic Cells by Means of Specific Interactions with Phosphatidylserine. Applications to Molecular Imaging by MRIC. BURTEA, S. LAURENT, E. LANCELOT, S. BALLET, O. MURARIU, O. ROUSSEAUX, M. PORT, L. VANDER ELST, C. COROT, R.N. MULLER, Mol. Pharm., 6(6):1903-19 (2009).
Calix[4]arenes as Molecular Platforms for Potential High-field MRI Contrast Agents .D.T. SCHÜHLE, U. HANEFELD, J. SCHATZ, S. LAURENT, L. VANDER ELST, R.N. MULLER, M.C.A. STUART, J.A. PETERS, Chem. Eur. J., 15 (13), 3290-3296 (2009)
Study of non covalent interactions between MRI contrast agents and human serum albumin by NMR diffusometry, C. Henoumont, L. Vander Elst, S. Laurent, R.N. MullerJ. Biol. Inorg. Chem. 14(5) (2009) 683-691
Synthèse et caractérisation du Gd-C4-thyroxin-DTPA, un nouvel agent de contraste potentiel pour l'IRM. Etude de son interaction non covalente avec l'albumine sérique humaine, C. Henoumont, L. Vander Elst, S. Laurent, R.N. MullerIngénierie et Recherche Bioméd. (IRBM) 30(4) (2009) 197-200
Optimised Synthetic Route for Tuneable Shell SiO2@Fe3O4 Core-Shell NanoparticlesC. Vogt, M.S. Toprak, J. Shi, N.F. Torres, B. Fadeel, S. Laurent, J.L. Bridot, R.N. Mller, et M. Muhammed, Materials Research Society Symposium Proceedings, (2008).
An assessment of the potential relationship between the charge of Gd-DTPA complexes and the exchange rate of the water coordinated to the metal.Laurent S., Vander Elst L., Botteman F., Muller R.N.Eur. J. Inorg. Chem. , F.I., 2,597, 28 (2008) 4369-4379
Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapyVitha T., Kubicek V., Herma,, P, Vander Elst L., Muller R.N., Kolar Z.I., Wolterkeek H.T., Breeman W.A., L,ukes I., Peters J.A.J. Med. Chem. ,51(3) , (2008), 677-683.
Pyridine-N-oxide Analogues of DOTA and Their Gadolinium(III) Complexes Endowed with a Fast Water Exchange on the Square-Antiprismatic Isomer (dagger), POLÁSEK M, SEDINOVÁ M, KOTEK J, VANDER ELST L, MULLER RN, HERMANN P, LUKES I. Inorg Chem., 48, 455-465 , 2008
Optimization of the Synthesis of Superparamagnetic Contrast Agents by the Design of Experiments MethodD. FORGE, A. ROCH, S. LAURENT, H. TELLEZ, Y. GOSSUIN, F. RENAUX, L. VANDER ELST, RN. MULLER, J. Phys. Chem C, 112 (49), 19178–19185 (2008)
Molecular imaging of αVβ3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.Burtea C., Laurent S., Murariu O., Rattat D., Toubeau G., Verbruggen A., Vansthertem D., Vander Elst L., Muller R.N.Cardiovasc. res, F.I.: 6,127, (2008), 78, 148-157.
Paramagnetic liposomes: inner versus outer membranes relaxivity of DPPC liposomes incorporating lipophilic gadolinium complexes.Laurent S., Vander Elst L., Thirifays C., Muller R.N.Langmuir, F.I.: 4,009, (2008), 24, 4347-4351.
Relaxivities of paramagnetic liposomes: on the importance of the chain type and the length of the amphiphilic complex.Laurent S., Vander Elst L., Thirifays C., Muller R.N.Eur. Biophys. J., F.I.:2,238, (2008), 37, 1007-1014.
Enzymatically prepared n-alkyl esters of glucuronic acid: the effect of freeze-drying conditions and hydrophobic chain length on thermal behavior.Blecker C., Danthine S., Pétré M., Lognay G., Moreau B., Vander Elst L., Paquot M., Deroanne C.J. Colloid Interf. Sci., F.I.: 2,309, (2008), 321, 154-158.
Contrast agents: magnetic resonanceBurtea C., Laurent S., Vander Elst L., Muller R.N.Handb. Exp. Pharmacol., (2008), 185, 135-165
Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: a comprehensive study,S. Boutry, S. Brunin, I. Mahieu, S. Laurent, L. Vander Elst, et R.N. Muller, Contrast Media & Molecular Imaging, 3(6), Nov. 2008, p. 223-232
Synthesis and manifold physicochemical characterization of a new gadolinium complex with a high affinity for human serum albuminHENOUMONT C., HENROTTE V., LAURENT S., VANDER ELST L., MULLER R.N. J. Inorg. Biochem., F.I.: 2,6540, 2008, 102, 721-30
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.Laurent S., Forge D., Port M., Roch A., Robic C., Vander Elst L., Muller R.N.Chem. Rev. F.I.:22.757, (2008), 108, 2064-2110.
Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease.Lionel Larbanoix; Carmen Burtea; Sophie Laurent; Fred Van Leuven; Gérard Toubeau; Luce Vander Elst; Robert N. MullerNeurobiology of Aging (2008) doi:10.1016/j.neurobiolaging.2008, Nov 21
Synthesis of a new gadolinium complex with a high affinity for human serum albumin and its manifold physicochemical characterization by proton relaxation rate analysis, NMR diffusometry and electrospray mass spectrometry C. Henoumont, V. Henrotte, S. Laurent, L. Vander Elst, R.N. MullerJ. Inorg. Biochem., (2008), 102(4): 721-730
The presence of halide salts influences the non-covalent interaction of MRI contrast agents and human serum albuminHenrotte, V; Muller, RN; Bartholet, A, et al.Contrast Media & Molecular Imaging, (2007), 2: 258-261
In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imagingS. Laurent, L. Vander Elst, C. Galaup, R.N. Muller, C. PicardBioorg Med Chem Lett., (2007), 17(22), 6230-6233 FI:2.478
From phage display to magnetophage, a new tool for magnetic resonance molecular imagingJ. Segers, C. Laumonier, C. Burtea, S. Laurent, L. Vander Elst, R.N. MullerBioconjug Chem., (2007), 18(4):1251-8
Comprehensive Investigation of the Non-Covalent Binding of MRI Contrast Agents with Human Serum AlbuminV. Henrotte, L. Vander Elst, S. Laurent, R.N. MullerJ. Biol. Inorg. Chem., 929-937 (2007) FI: 3.224
A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography?Yu G, Yamashita M, Aoshima K, Takahashi M, Oshikawa T, Takayanagi H, Laurent S, Burtea C, Vander Elst L, Muller RN.Bioorg Med Chem Lett., 17(8), 2246-9 (2007) FI: 2.478
Hybrid gadolinium oxide nanoparticles : multimodal contrast agents for in vivo imagingJ.-L. Bridot, A.-C. Faure, S. Laurent, C. Rivière, C. Billotey, B. Hiba, M. Janier, V. Josserand, J.-L. Coll, L. Vander Elst, R.N. Muller, S. Roux, P. Perriat, O. TillementJ. Am. Chem. Soc., 129, 5076-5084 (2007) FI: 7.419
Synthesis and Physicochemical Characterization of New C-functionalized derivatives of Gadolinium 3,6,10-Tris(carboxymethyl)-3,6,10-triazadodecanoate (Gd-TTDA) Exhibiting Fast Water Exchange, Potential Paramagnetic Reporters for Molecular ImagingS. Laurent, L. Vander Elst, A. Vroman, R.N. MullerHelv. Chim. Acta, 90(3), 562-573 (2007) FI: 1.650
Monodisperse Water-Soluble Superparamagnetic Iron Oxide Nanoparticles Revealed as High-Performance T2 Contrast AgentsJ. Qin, S. Laurent, Y. Suk Jo, A. Roch, M. Mikhaylova, R.N. Muller, M. MuhammedAdv. Mater.,19, 1874-1878 (2007) FI: 9.107
Relaxation by clustered ferritin: a model for ferritin-induced relaxation in vivo. Gossuin Y, Gillis P, Muller RN, Hocq A.NMR Biomed., 20(8): 749-756 (2007)
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.Taboada E, Rodriguez E, Roig A, Oro J, Roch A, Muller RN.Langmuir. 2007 Apr 10;23(8):4583-8
The presence of halide salts influences the non-covalent interaction of MRI contrast agents and human serum albuminHENROTTE V., MULLER R.N., BARTHOLET A., VANDER ELST L. Contrast Med. Mol. Imaging, 2007, 2, 258-261
Bis(phenetylamide) derivatives of Gd-DTPA as potential receptor-specific MRI contrast agents S. Laurent, T.N. Parac-Vogt, K. Kimpe, C. Thirifays, K. Binnemans, R.N. Muller, L. Vander Elst Eur. J. Inorg. Chem., 2061-2067 (2007) FI:2.514
Impact of rigidification on relaxometric properties of a tricyclic tetraazatriacetic gadolinium chelate. Port M, Raynal I, Vander Elst L, Muller RN, Dioury F, Ferroud C, Guy A. Contrast Media Mol Imaging. (2006) May;1(3):121-7.
Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity T.N. Parac-Vogt, L. Vander Elst, K. Kimpe, S. Laurent, C. Burtéa, F. Chen, R. Van Deun, Y. Ni, R.N. Muller, K. Binnemans Contrast Med. Mol. Imaging, 1(6), 267-278 (2006)
A dual lanthanide probe suitable for optical (Tb3+ luminescence) and magnetic resonance imaging (Gd3+ relaxometry) N. Geum, I. Nasso, B. Mestre, P. Tisnès, C. Picard, S. Laurent, R.N. Muller, L. Vander Elst Bioorg.Med.Chem.Lett.,16, 5309-5312 (2006)
Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents S. Laurent, L. Vander Elst, R.N. Muller Contrast Med. Mol. Imaging, 1(3), 128-137 (2006)
Specific E-selectin targeting with a superparamagnetic MRI contrast agent S. Boutry, S. Laurent, L. Vander Elst, R.N. MullerContrast Med. Mol. Imaging, 1(1), 15-22 (2006)
A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology C. Laumonier, J. Segers, S. Laurent, A. Michel, F. Coppée, A. Belayew, L. Vander Elst, R.N. Muller J. Biomol. Screening, 11(5), 537-545 (2006)
Relaxometric Study of Copper [15]Metallacrown-5 Gadolinium Complexes Derived from alpha-Aminohydroxamic Acids T.N. Parac-Vogt, A. Pacco, P. Nockemann, S. Laurent, R.N. Muller, M. Wickleder, G. Meyer, L. Vander Elst, K. Binnemans Chem Eur J, 12(1):204-210 (2006)
Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imagingPARAC-VOGT T.N., KIMPE K., LAURENT S., PIERAR C., VANDER ELST L., MULLER R. N., BINNEMANS K.Eur. Biophys. J., F.I.: 3,2600, 2006, 35, 136-140
Publications plus anciennes (2000-2005)
Evaluation of Gd-EOB-DTPA uptake in a perfused and isolated mouse liver model: correlation between magnetic resonance imaging and monochromatic quantitative computed tomography. Segers J, Le Duc G, Laumonier C, Tropres I, Elst LV, Muller RN. Invest Radiol. 2005 Sep;40(9):574-82.